Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michele DesMarais"'
Autor:
Sandy Feng, Michele DesMarais, Abraham Shaked, K. Rajender Reddy, Oren Shaked, Jeffrey D. Punch, Jack Demetris, Jorge Reyes, Peter H. Sayre, Goran B. Klintmalm, Whitney Jackson, Josh Levitsky, Bao-Li Loza
Publikováno v:
Transplantation
Transplantation, vol 106, iss 1
Transplantation, vol 106, iss 1
BackgroundDeceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosi
Autor:
Peter H. Sayre, Matthew J Everly, Josh Levitsky, Abraham Shaked, Michele DesMarais, Sandy Feng, Vadim Jucaud
Publikováno v:
Hepatology. 69:1273-1286
The development of human leukocyte antigen (HLA) donor-specific antibody/antibodies (DSA) is not well described in liver transplant (LT) patients undergoing immunosuppression (IS) withdrawal protocols despite the allograft risk associated with de nov
Autor:
Todd C. Hankinson, Sydney Grob, Rajeev Vibhakar, Anandani Nellan, Jean M. Mulcahy Levy, Nicholas K. Foreman, Michele Desmarais, Andrew Morin, Adam L. Green, Brent E. Fitzwalter, Shadi Zahedi
Publikováno v:
Cell Death and Disease, Vol 10, Iss 9, Pp 1-15 (2019)
Autophagy is a multistage process. Progress within the field has led to the development of agents targeting both early (initiation) and late (fusion) stages of this process. The specific stage of autophagy targeted may influence cancer treatment outc
Autor:
Shadi, Zahedi, Brent E, Fitzwalter, Andrew, Morin, Sydney, Grob, Michele, Desmarais, Anandani, Nellan, Adam L, Green, Rajeev, Vibhakar, Todd C, Hankinson, Nicholas K, Foreman, Jean M, Mulcahy Levy
Publikováno v:
Cell Death & Disease
Autophagy is a multistage process. Progress within the field has led to the development of agents targeting both early (initiation) and late (fusion) stages of this process. The specific stage of autophagy targeted may influence cancer treatment outc
Autor:
Abraham Shaked, Allison Priore, Goran B. Klintmalm, Sandy Feng, Bryna E. Burrell, Nancy D. Bridges, H. Kopetskie, Anthony J. Demetris, Jeffrey D. Punch, Jorge Reyes, Michele DesMarais, Peter H. Sayre, Josh Levitsky
Publikováno v:
Am J Transplant
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 19, iss 5
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 19, iss 5
The Immune Tolerance Network ITN030ST A-WISH assessed immunosuppression withdrawal in liver transplant recipients with hepatitis C or nonimmune nonviral liver disease. Of 275 recipients enrolled before transplantation, 95 were randomly assigned 4:1 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e7cefcfcaeeea22e0acb5d10d6075b
https://europepmc.org/articles/PMC6482056/
https://europepmc.org/articles/PMC6482056/
Autor:
B. Chang, Brendan J. Keating, Toumy Guettouche, Abraham Shaked, Peter H. Sayre, Michael R. Barnes, Smita Asare, Michele DesMarais, Michael V. Holmes, Yun Li
Publikováno v:
Hepatology. 65:269-280
The ability to noninvasively diagnose acute cellular rejection (ACR) with high specificity and sensitivity would significantly advance personalized liver transplant recipient care and management of immunosuppression. We performed microRNA (miRNA) pro
Autor:
A. M. J. Shapiro, Enrico Cagliero, S. Booher, Peter Bianchine, Peter H. Sayre, Rodolfo Alejandro, Julia S. Goldstein, H. Kopetskie, Daniel C. Brennan, Michele DesMarais
Publikováno v:
American Journal of Transplantation. 16:509-517
We report the long-term follow-up of the efficacy and safety of islet transplantation in seven type 1 diabetic subjects from the United States enrolled in the multicenter international Edmonton Protocol who had persistent islet function after complet
Autor:
Lindsey M. Hoffman, Adam L. Green, Rajeev Vibhakar, Shadi Zahedi, Michele Desmarais, Andrea Griesinger, Angela Pierce, Jean M. Mulcahy Levy, Irina Alimova, Andrew Morin, Caroline Soane
Atypical Teratoid/Rhabdoid tumor (AT/RT), characterized by loss-of-function mutations in the SMARCB1 component of the SWI/SNF chromatin-remodeling complex, remains a difficult-to-treat tumor with a five-year overall survival rate of 15–45%. Proteas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128ee6c423437e697f19b0880e919043
https://europepmc.org/articles/PMC6011927/
https://europepmc.org/articles/PMC6011927/
Publikováno v:
Transplantation. 102:S623
Publikováno v:
Transplantation. 102:S203